What is aTyr Pharma's financing cash flow?

aTyr Pharma (ATYR) reported financing cash flow of -$142K in Q1 2026.

How has aTyr Pharma's financing cash flow changed year-over-year?

aTyr Pharma's financing cash flow decreased by 100.8% year-over-year, from $18.63M to -$142K.

What is the long-term trend for aTyr Pharma's financing cash flow?

Over 4 years (2021 to 2025), aTyr Pharma's financing cash flow has grown at a -11.9% compound annual growth rate (CAGR), from $110.03M to $66.14M.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

aTyr Pharma ATYR Financing Cash Flow

Financing Cash Flow at other companies

Bristol-Myers SquibbBMY

-$1.56B-57.1%

Merck & Co.MRK

-$2.98B+48.2%

United TherapeuticsUTHR

-$1.48B-1,483%

Design Therapeutics, Inc.DSGN

$19.93M+86,570%

CytomX TherapeuticsCTMX

$234.49M—

Vor BiopharmaVOR

$74.87M+12,455%

Other financials

Income statement

See full

Revenue-—

Operating income-$11.4M+27.5%

Net income-$10.8M+27.5%

EPS (diluted)-$0.11+35.3%

Balance sheet

See full

Cash & equivalents$10.0M-3.4%

Total debt$12.3M-9.2%

Total equity$57.9M-22.8%

Total assets$79.7M-18.1%

Cash flow

See full

Operating cash flow-$12.5M+18.8%

CapEx$138.0K—

Free cash flow-$12.7M+17.9%

Valuation

See full

Market cap$54.88M-88.2%

Enterprise value$57.17M—

P/S288.8×—

Profitability

See full

Operating margin-40,856.3%+28,833pp

Net margin-39,009.5%+29,653pp

FCF margin-32,664.7%+4,018pp

Returns & leverage

See full

Return on equity-105.3%+50.6pp

Debt / equity0.2×0.0×

Current ratio5.8×-2.0×

Where this comes from

Reported directly by aTyr Pharma in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is aTyr Pharma's financing cash flow?: aTyr Pharma (ATYR) reported financing cash flow of -$142K in Q1 2026.
How has aTyr Pharma's financing cash flow changed year-over-year?: aTyr Pharma's financing cash flow decreased by 100.8% year-over-year, from $18.63M to -$142K.
What is the long-term trend for aTyr Pharma's financing cash flow?: Over 4 years (2021 to 2025), aTyr Pharma's financing cash flow has grown at a -11.9% compound annual growth rate (CAGR), from $110.03M to $66.14M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.